000026160 000__ 01210cam\a2200409\i\4500
000026160 001__ 26160
000026160 003__ SzGeWIPO
000026160 005__ 20240708162352.0
000026160 008__ 071015s2010    enk|||||r|||| 00| 0 eng d
000026160 035__ $$a(wipo)0
000026160 035__ $$a(OCoLC)1160233976
000026160 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026160 041__ $$aeng
000026160 050_4 $$aK5$$b.U72
000026160 08204 $$a346.4048$$220
000026160 084__ $$aGB 10
000026160 1001_ $$aMatilal, Shreya.,$$eauthor.
000026160 24510 $$aDo developing countries need a pharmaceutical data-exclusivity regime/? /$$cS. Matilal.
000026160 264_1 $$aLondon, England :$$bSweet & Maxwell,$$c2010.
000026160 300__ $$a1 volume ([9] pages) ;$$c[28] cm.
000026160 336__ $$atext$$btxt$$2rdacontent
000026160 337__ $$aunmediated$$bn$$2rdamedia
000026160 338__ $$avolume$$bnc$$2rdacarrier
000026160 4901_ $$aEuropean Intellectual Property Review (EIPR),$$x0142-0461 ;$$v2010, Vol. 32, No. 6, pages 268-276
000026160 650_0 $$aIntellectual property$$zEurope.
000026160 650_0 $$aIntellectual property$$zDeveloping countries.
000026160 650_4 $$aPharmaceuticals
000026160 650_4 $$aTRIPS Agreement$$zDeveloping countries
000026160 650_6 $$aPropriété intellectuelle$$zEurope.
000026160 651_0 $$aDeveloping countries$$xCommerce$$xLaw and legislation.
000026160 830_0 $$aEuropean Intellectual Property Review (EIPR) ;$$v2010, Vol. 32, No. 6, pages 268-276.
000026160 903__ $$aEuropean Intellectual Property Review (EIPR).
000026160 904__ $$aJournal article
000026160 942__ $$cART$$2ddc
000026160 952__ $$w2010-09-29$$p2010-0867$$u40365$$bMAIN$$10$$kGB 10$$v2010-09-29$$zLibrary$$71$$cLibrary
000026160 980__ $$aBIB
000026160 999__ $$c28549$$d28549